Literature DB >> 12117926

Leishmania promastigotes release a granulocyte chemotactic factor and induce interleukin-8 release but inhibit gamma interferon-inducible protein 10 production by neutrophil granulocytes.

G van Zandbergen1, N Hermann, H Laufs, W Solbach, T Laskay.   

Abstract

Recent data from our laboratory suggest that neutrophil granulocytes (polymorphonuclear leukocytes [PMN]) can serve as host cells for Leishmania major in the early phase of infection. In line with these findings, an early influx of PMN to the infected tissues was shown by others to be associated with susceptibility to infection with L. major. The mechanisms underlying the initial PMN recruitment to the site of infection is poorly understood. In the present study we investigated whether Leishmania can influence PMN migration. Supernatants of Leishmania promastigotes were tested for their chemotactic activity using an in vitro chemotaxis assay. All Leishmania species tested (L. major, L. aethiopica, and L. donovani) displayed a marked chemotactic effect on human PMN. However, no effect on the migration of macrophages and NK cells was observed. Checkerboard analysis revealed that the observed PMN migration was due to chemotaxis rather than chemokinesis. Most of the chemotactic activity was found in fractions containing molecules with sizes between 10 and 50 kDa. Pretreatment of PMN with N-formyl-methionyl-leucyl-phenylalanine blocked the chemotactic activity of Leishmania supernatants up to 75%. In addition, we found that leishmanial contact induced the release of interleukin-8 (IL-8) and inhibited the production of gamma interferon-inducible protein 10 (IP-10) by PMN. These data suggest that infection with Leishmania promastigotes leads to PMN accumulation via the production of a chemotactic factor by the parasites, and this effect is amplified by the induction of IL-8 production in PMN. On the other hand, the inhibition of IP-10 production can lead to prevention of NK cell activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12117926      PMCID: PMC128123          DOI: 10.1128/IAI.70.8.4177-4184.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  T21/DP107, A synthetic leucine zipper-like domain of the HIV-1 envelope gp41, attracts and activates human phagocytes by using G-protein-coupled formyl peptide receptors.

Authors:  S B Su; J l Gao; W h Gong; N M Dunlop; P M Murphy; J J Oppenheim; J M Wang
Journal:  J Immunol       Date:  1999-05-15       Impact factor: 5.422

2.  Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions.

Authors:  S Leuenroth; C Lee; P Grutkoski; H Keeping; H H Simms
Journal:  Surgery       Date:  1998-08       Impact factor: 3.982

3.  The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.

Authors:  A Ludwig; F Petersen; S Zahn; O Götze; J M Schröder; H D Flad; E Brandt
Journal:  Blood       Date:  1997-12-01       Impact factor: 22.113

4.  Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major.

Authors:  B Vester; K Müller; W Solbach; T Laskay
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

5.  Discrete steps in binding and signaling of interleukin-8 with its receptor.

Authors:  L Wu; N Ruffing; X Shi; W Newman; D Soler; C R Mackay; S Qin
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

6.  Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.

Authors:  T M Scharton; P Scott
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

7.  Resistance of mice to experimental leishmaniasis is associated with more rapid appearance of mature macrophages in vitro and in vivo.

Authors:  C Sunderkötter; M Kunz; K Steinbrink; G Meinardus-Hager; M Goebeler; H Bildau; C Sorg
Journal:  J Immunol       Date:  1993-11-01       Impact factor: 5.422

8.  Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils.

Authors:  S Gasperini; M Marchi; F Calzetti; C Laudanna; L Vicentini; H Olsen; M Murphy; F Liao; J Farber; M A Cassatella
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

9.  Neutrophil chemotactic factors secreted from Toxoplasma gondii.

Authors:  M Nakao; E Konishi
Journal:  Parasitology       Date:  1991-08       Impact factor: 3.234

10.  Natural killer cells participate in the early defense against Leishmania major infection in mice.

Authors:  T Laskay; M Röllinghoff; W Solbach
Journal:  Eur J Immunol       Date:  1993-09       Impact factor: 5.532

View more
  49 in total

1.  Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania major.

Authors:  Anne-Christin Lamerz; Sebastian Damerow; Barbara Kleczka; Martin Wiese; Ger van Zandbergen; Jens Lamerz; Alexander Wenzel; Fong-Fu Hsu; John Turk; Stephen M Beverley; Françoise H Routier
Journal:  Glycobiology       Date:  2010-03-24       Impact factor: 4.313

2.  CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung.

Authors:  Daniel P Widney; Yan Hu; Amy K Foreman-Wykert; Kim C Bui; Tam T Nguyen; Bao Lu; Craig Gerard; Jeff F Miller; Jeffrey B Smith
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

3.  Regulation of impaired protein kinase C signaling by chemokines in murine macrophages during visceral leishmaniasis.

Authors:  Ranadhir Dey; Arup Sarkar; Nivedita Majumder; Suchandra Bhattacharyya Majumdar; Kaushik Roychoudhury; Sandip Bhattacharyya; Syamal Roy; Subrata Majumdar
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Chronicity of dermal leishmaniasis caused by Leishmania panamensis is associated with parasite-mediated induction of chemokine gene expression.

Authors:  Adriana Navas; Deninson Alejandro Vargas; Marina Freudzon; Diane McMahon-Pratt; Nancy Gore Saravia; María Adelaida Gómez
Journal:  Infect Immun       Date:  2014-04-21       Impact factor: 3.441

5.  Circulating and bone marrow myeloid cells containing Leishmania amastigotes in a case of advanced canine leishmaniosis.

Authors:  Ioannis L Oikonomidis; Theodora K Tsouloufi; Mathios E Mylonakis; Dimitra Psalla; Nectarios Soubasis; Timoleon Rallis; Maria Kritsepi-Konstantinou
Journal:  J Vet Diagn Invest       Date:  2019-07-05       Impact factor: 1.279

6.  Mechanisms of immune evasion in leishmaniasis.

Authors:  Gaurav Gupta; Steve Oghumu; Abhay R Satoskar
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

7.  Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection.

Authors:  René E Vasquez; Lijun Xin; Lynn Soong
Journal:  Infect Immun       Date:  2007-11-12       Impact factor: 3.441

8.  Chemokine gene expression in toll-like receptor-competent and -deficient mice infected with Leishmania major.

Authors:  Simone Antoniazi; Helen P Price; Pascale Kropf; Marina A Freudenberg; Chris Galanos; Deborah F Smith; Ingrid Müller
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  Keratinocytes determine Th1 immunity during early experimental leishmaniasis.

Authors:  Jan M Ehrchen; Kirsten Roebrock; Dirk Foell; Nadine Nippe; Esther von Stebut; Johannes M Weiss; Niels-Arne Münck; Dorothee Viemann; Georg Varga; Carsten Müller-Tidow; Hans-Joachim Schuberth; Johannes Roth; Cord Sunderkötter
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

Review 10.  The prominent role of neutrophils during the initial phase of infection by Leishmania parasites.

Authors:  Mélanie Charmoy; Floriane Auderset; Cindy Allenbach; Fabienne Tacchini-Cottier
Journal:  J Biomed Biotechnol       Date:  2009-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.